Dermatologist at The Center for Dermatology and Laser Surgery
Dermatology
Dr. Emil A. Tanghetti, MD
|
|
Give Review
Emil Tanghetti is an expert in the field of Dermatology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He received awards:"Super Doctor", "Top MD" and "Fellow (FAAD)". Dr. Emil A. Tanghetti has written publications. He has 46 publications published with PubMed. The lastest paper is: 'Long pulse 532-nm laser treatment of facial telangiectasia.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Understanding the burden of adult female Acne.
- Commentary: Treatment and Prevention of Surgical Scars: To Bruise or Not to Bruise is No Longer the Question, but Rather Who Pays for the Treatment.
- The Role of Inflammation in the Pathology of Acne.
- An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.
- Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece.
- Characterization of an optimized light source and comparison to pulsed dye laser for superficial and deep vessel clearance.
- The role of topical vitamin D modulators in psoriasis therapy.
- A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
- Complications of laser dermatologic surgery.
- Combination therapy is the standard of care.
- Topical tazarotene in Acne vulgaris: treatment approaches.
- Multipass treatment of photodamage using the pulse dye laser.
- Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
- Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial Acne vulgaris: a double-blind randomized trial.
- Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial Skin: a multicenter, double-blind, randomized study.
- Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of Actinic keratoses on the face and scalp.
- The impact and importance of resistance.
- Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
- Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial Acne vulgaris.
- Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate Acne.
- A 3-step Acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
- Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
- Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of Acne management.
- Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial Acne vulgaris.
- A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne.
- Clinical evidence for the role of a topical anti-inflammatory agent in comedonal Acne: findings from a randomized study of dapsone gel 5% in combination with tazaroten...
- New perspectives on benzoyl peroxide use in inflammatory and comedonal Acne treatment. Introduction.
- The evolution of benzoyl peroxide therapy.
- Optimizing topical therapies for treating psoriasis: a consensus conference.
- The effects of pulse dye laser double-pass treatment intervals on depth of vessel coagulation.
- The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of Skin tolerability and eval...
- Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of Acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
- A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
- Optimizing the use of tazarotene for the treatment of facial Acne vulgaris through combination therapy.
- Evaluation of pulse-duration on purpuric threshold using extended pulse pulsed dye laser (cynosure V-star).
- Photometric and clinical assessment of localized UVB phototherapy systems for the high-dosage treatment of stable plaque psoriasis.
- Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star).
- Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial Skin: a multicenter, double-blind, randomized, parallel-group study.
- Topical retinoids in the treatment of Acne vulgaris.
- An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
- An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients swItched from treatment with calcipotriene +/- ...
- Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial Acne vulgaris: a randomized trial.
- Long pulse 532-nm laser treatment of facial telangiectasia.
- The biological consequences of cutaneous laser surgery.
- The noncompliant patient with Acne.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
University Tex Southwestern
Harvard Med
Massachusetts General Hospital
Stanford University Med Center
Harvard Med School
Procedures Preformed
- Acne Surgery
- Dermal Filler
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Super Doctor
- Top MD
- Fellow (FAAD)
Education
-
Massachusetts General Hospital -
Stanford University -
David Geffen School of Medicine at UCLA
Hospital
-
Sutter Medical Center, Sacramento
Drug Facts
| NPI NUMBER | 1043250145 | |
| NPPES Provider LastName | TANGHETTI | |
| NPPES Provider FirstName | EMIL | |
| NPPES Provider ZIPCode | 958193948 | |
| NPPES Provider State | CA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1916.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043250145 |
| Last Name Of The Provider | TANGHETTI |
| First Name Of The Provider | EMIL |
| View All |
Similar Doctors
|
Dr. Jayne S. Joo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elliott L. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan K. Silva, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jacqueline M. Calkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sepideh Bagheri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maxwell A. Fung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miki S. Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas H. King, MD |
|
Dr. Jesse M. Kramer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Trauner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Summer R. Youker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shurong Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chai S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Balvinder K. Rehal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa A. Reyes, MD |
|
|
Dr. Neha Prakash, MD
This Doctor is OpenDoctor Recommended.
|